{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:22:02Z","timestamp":1793726522114,"version":"4.6.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Vigo\/CISUG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10787-022-01027-6","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T15:03:43Z","timestamp":1661958223000},"page":"2017-2026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals"],"prefix":"10.1007","volume":"30","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Faidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-7300","authenticated-orcid":false,"given":"Hebatallah M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Simal-Gandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"issue":"4","key":"1027_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2214\/AJR.14.13021","volume":"203","author":"AM Ajlan","year":"2014","unstructured":"Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol 203(4):782\u2013787","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1027_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43055-021-00484-3","volume":"52","author":"RM Ali","year":"2021","unstructured":"Ali RM, Ghonimy MB (2021) Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients. Egypt J Radiol Nucl Med 52(1):1\u20138","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"1","key":"1027_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43162-021-00064-x","volume":"33","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2021) Acute kidney injury and COVID-19. Egypt J Intern Med 33(1):1\u20135","journal-title":"Egypt J Intern Med"},{"issue":"3","key":"1027_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/bbrj.bbrj_103_20","volume":"4","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Al-Naimi MS, Lungnier CM, Al-Gareeb AI (2020a) Macrolides and COVID-19: an optimum premise. Biomed Biotechnol Res J 4(3):189","journal-title":"Biomed Biotechnol Res J"},{"key":"1027_CR5","first-page":"151","volume-title":"Selected chapters from the reninangiotensin system","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Al-Niemi MS, Hussain NR, Al-Gareeb AI, Al-Harchan NA, Al-Kurashi AH (2020b) The Potential Role of Renin Angiotensin System (RAS) and Dipeptidyl Peptidase-4 (DPP-4) in COVID-19: Navigating the Uncharted. In: Kibel A (ed) Selected chapters from the reninangiotensin system. IntechOpen, London, pp 151\u2013165"},{"key":"1027_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmed.2021.644295","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Cruz-Martins N, Batiha GE (2021a) COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type II diabetes mellitus: the anti-inflammatory role of metformin. Front Med 8:110","journal-title":"Front Med"},{"key":"1027_CR7","doi-asserted-by":"publisher","first-page":"649128","DOI":"10.3389\/fnut.2021.649128","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, Batiha GE (2021b) The looming effects of estrogen in Covid-19: a rocky rollout. Front Nutr 8:649128","journal-title":"Front Nutr"},{"key":"1027_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102008","volume":"67","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusty N, Cruz-Martins N, Batiha GE (2021c) Sequential doxycycline and colchicine combination therapy in Covid-19: the salutary effects. Pulm Pharmacol Ther 67:102008","journal-title":"Pulm Pharmacol Ther"},{"key":"1027_CR9","first-page":"1","volume":"26","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Habotta OA, Batiha GE (2022) High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons. Inflammopharmacology 26:1","journal-title":"Inflammopharmacology"},{"key":"1027_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fcvm.2021.644095","volume":"8","author":"H Al-kuraishy","year":"2021","unstructured":"Al-kuraishy H, Al-Gareeb AI, Guerreiro SG, Cruz-Martins N, Batiha GE (2021d) COVID-19 in relation to hyperglycemia and diabetes mellitus. Front Cardiovasc Med 8:335","journal-title":"Front Cardiovasc Med"},{"key":"1027_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fmed.2021.606678","volume":"8","author":"L Amarelle","year":"2021","unstructured":"Amarelle L, Quintela L, Hurtado J, Malacrida L (2021) Hyperoxia and lungs: what we have learned from animal models. Front Med 8:235","journal-title":"Front Med"},{"issue":"5","key":"1027_CR12","doi-asserted-by":"publisher","first-page":"L852","DOI":"10.1152\/ajplung.00324.2019","volume":"318","author":"A Aravamudhan","year":"2020","unstructured":"Aravamudhan A, Haak AJ, Choi KM, Meridew JA, Caporarello N, Jones DL, Tan Q, Ligresti G, Tschumperlin DJ (2020) TBK1 regulates YAP\/TAZ and fibrogenic fibroblast activation. Am J Physiol Lung Cell Mol Physiol 318(5):L852\u2013L863","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"1027_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240149","volume":"15","author":"L Artigas","year":"2020","unstructured":"Artigas L, Coma M, Matos-Filipe P, Aguirre-Plans J, Farr\u00e9s J, Valls R, Fernandez-Fuentes N, de la Haba-Rodriguez J, Olvera A, Barbera J, Morales R (2020) In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm. PLoS\u00a0One 15(10):e0240149","journal-title":"PLoS\u00a0One"},{"issue":"66","key":"1027_CR14","doi-asserted-by":"publisher","first-page":"40264","DOI":"10.1039\/D0RA06038K","volume":"10","author":"VM Balaramnavar","year":"2020","unstructured":"Balaramnavar VM, Ahmad K, Saeed M, Ahmad I, Kamal M, Jawed T (2020) Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro. RSC Adv 10(66):40264\u201340275","journal-title":"RSC Adv"},{"issue":"6","key":"1027_CR15","doi-asserted-by":"publisher","first-page":"e20200652","DOI":"10.1084\/jem.20200652","volume":"217","author":"BJ Barnes","year":"2020","unstructured":"Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Da\u00dfler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M (2020) Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med 217(6): e20200652","journal-title":"J Exp Med"},{"key":"1027_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fcell.2019.00049","volume":"7","author":"GT Boopathy","year":"2019","unstructured":"Boopathy GT, Hong W (2019) Role of hippo pathway-YAP\/TAZ signaling in angiogenesis. Front Cell Dev Biol 7:49","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1027_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/thoraxjnl-2013-203581","volume":"69","author":"PO Bridevaux","year":"2014","unstructured":"Bridevaux PO, Aubert JD, Soccal PM, Mazza-Stalder J, Berutto C, Rochat T, Turin L, Van Belle S, Nicod L, Meylan P, Wagner G (2014) Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax 69(1):32\u201338","journal-title":"Thorax"},{"issue":"13","key":"1027_CR18","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2165\/11207710-000000000-00000","volume":"71","author":"NJ Carter","year":"2011","unstructured":"Carter NJ (2011) Pirfenidone Drugs 71(13):1721\u20131732","journal-title":"Pirfenidone Drugs"},{"issue":"9","key":"1027_CR19","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41418-018-0250-0","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zhao X, Sun J, Su W, Zhang L, Li Y, Liu Y, Zhang L, Lu Y, Shan H, Liang H (2019) YAP1\/twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF. Cell Death Differ 26(9):1832\u20131844","journal-title":"Cell Death Differ"},{"key":"1027_CR20","doi-asserted-by":"crossref","unstructured":"Co JL, Badilles FA, Halun CB, Dy-Agra GN, Campomanes CM, Pagcatipunan RS, Divinagracia RM (2022) Pirfenidone for COVID-19 Associated Pulmonary Fibrosis: A Case Series. InC38. RARE AND COMMON ILDS: EPIDEMIOLOGY, DIAGNOSIS, AND MANAGEMENT 2022 May (pp. A4046-A4046). American Thoracic Society.","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A4046"},{"issue":"2","key":"1027_CR21","doi-asserted-by":"publisher","first-page":"2001808","DOI":"10.1183\/13993003.01808-2020","volume":"56","author":"M Combet","year":"2020","unstructured":"Combet M, Pavot A, Savale L, Humbert M, Monnet X (2020) Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19. Eur Respir J 56(2):2001808","journal-title":"Eur Respir J"},{"issue":"3","key":"1027_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4103\/ijri.IJRI_469_16","volume":"27","author":"KM Das","year":"2017","unstructured":"Das KM, Lee EY, Singh R, Enani MA, Al Dossari K, Van Gorkom K, Larsson SG, Langer RD (2017) Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging 27(3):342","journal-title":"Indian J Radiol Imaging"},{"issue":"2","key":"1027_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/mi.2017.77","volume":"11","author":"L Denney","year":"2018","unstructured":"Denney L, Branchett W, Gregory LG, Oliver RA, Lloyd CM (2018) Epithelial-derived TGF-\u03b21 acts as a pro-viral factor in the lung during influenza A infection. Mucosal Immunol 11(2):523\u2013535","journal-title":"Mucosal Immunol"},{"issue":"11","key":"1027_CR24","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00228-020-02947-4","volume":"76","author":"F Ferrara","year":"2020","unstructured":"Ferrara F, Granata G, Pelliccia C, La Porta R, Vitiello A (2020) The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2. Eur J Clin Pharmacol 76(11):1615\u20131618","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1027_CR25","first-page":"56","volume":"43","author":"E Fila","year":"2021","unstructured":"Fila E, Rocco I, Rocco G, Zuccon U, Ruberti E (2021) Recommendations for the respiratory rehabilitation of hospitalized and discharged COVID-19 patients: a sistematic review. G Ital Med Lav Erg 43(1):56\u201365","journal-title":"G Ital Med Lav Erg"},{"issue":"4","key":"1027_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008692","volume":"16","author":"C Goda","year":"2020","unstructured":"Goda C, Balli D, Black M, Milewski D, Le T, Ustiyan V, Ren X, Kalinichenko VV, Kalin TV (2020) Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway. PLoS Genet 16(4):e1008692","journal-title":"PLoS Genet"},{"issue":"6","key":"1027_CR27","doi-asserted-by":"publisher","first-page":"e98738","DOI":"10.1172\/jci.insight.98738","volume":"3","author":"JJ Gokey","year":"2018","unstructured":"Gokey JJ, Sridharan A, Xu Y, Green J, Carraro G, Stripp BR, Perl AK, Whitsett JA (2018) Active epithelial Hippo signaling in idiopathic pulmonary fibrosis. JCI Insight 3(6):e98738","journal-title":"JCI Insight"},{"issue":"4","key":"1027_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30582-X","volume":"21","author":"F Grillo","year":"2021","unstructured":"Grillo F, Barisione E, Ball L, Mastracci L, Fiocca R (2021) Lung fibrosis: an undervalued finding in COVID-19 pathological series. Lancet Infect Dis 21(4):e72","journal-title":"Lancet Infect Dis"},{"key":"1027_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2020.05.007","volume":"144","author":"JM Grimes","year":"2020","unstructured":"Grimes JM, Grimes KV (2020) p38 MAPK inhibition: a promising therapeutic approach for COVID-19. J Mol Cell Cardiol 144:63\u201365","journal-title":"J Mol Cell Cardiol"},{"key":"1027_CR30","doi-asserted-by":"publisher","unstructured":"Gu Y, Cao J, Zhang X, Gao H, Wang Y, Wang J, Zhang J, Shen G, Jiang X, Yang J, Zheng X (2020) Interaction network of SARS-CoV-2 with host receptome through spike protein. https:\/\/doi.org\/10.1101\/2020.09.09.287508","DOI":"10.1101\/2020.09.09.287508"},{"issue":"516","key":"1027_CR31","doi-asserted-by":"publisher","first-page":"eaau6296","DOI":"10.1126\/scitranslmed.aau6296","volume":"11","author":"AJ Haak","year":"2019","unstructured":"Haak AJ, Kostallari E, Sicard D, Ligresti G, Choi KM, Caporarello N, Jones DL, Tan Q, Meridew J, Espinosa AM, Aravamudhan A (2019) Selective YAP\/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis. Sci Transl Med 11(516):eaau6296","journal-title":"Sci Transl Med"},{"key":"1027_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbi.2020.05.059","volume":"87","author":"M Hamer","year":"2020","unstructured":"Hamer M, Kivim\u00e4ki M, Gale CR, Batty GD (2020) Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK. Brain Behav Immun 87:184\u2013187","journal-title":"Brain Behav Immun"},{"key":"1027_CR33","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s13063-020-04696-2","volume":"21","author":"PI Johansson","year":"2020","unstructured":"Johansson PI, Bestle M, S\u00f8e-Jensen P, Kristiansen KT, Stensballe J, Clausen NE, Perner A (2020) The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng\/kg\/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials 21:746","journal-title":"Trials"},{"key":"1027_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","volume":"43","author":"H Kai","year":"2020","unstructured":"Kai H, Kai M (2020) Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens Res 43:648\u2013654","journal-title":"Hypertens Res"},{"issue":"4","key":"1027_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/0960327120964543","volume":"40","author":"A Karamian","year":"2021","unstructured":"Karamian A, Paktinat S, Esfandyari S, Nazarian H, Ziai SA, Zarnani AH, Salehpour S, Hosseinirad H, Karamian A, Novin MG (2021) Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells. Hum Exp Toxicol 40(4):649\u2013660","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"1027_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5005\/jp-journals-10071-23733","volume":"25","author":"B Kayarat","year":"2021","unstructured":"Kayarat B, Khanna P, Sarkar S (2021) Pulmonary fibrosis in COVID-19 recovered patients: problem and potential management. Indian J Crit Care Med 25(2):242\u2013244","journal-title":"Indian J Crit Care Med"},{"issue":"11","key":"1027_CR37","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3348\/kjr.2020.0707","volume":"21","author":"S Kayhan","year":"2020","unstructured":"Kayhan S, Kocako\u00e7 E (2020) Pulmonary fibrosis due to COVID-19 pneumonia. Korean J Radiol 21(11):1273","journal-title":"Korean J Radiol"},{"issue":"6","key":"1027_CR38","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1165\/rcmb.2006-0379TR","volume":"37","author":"M Konigshoff","year":"2007","unstructured":"Konigshoff M, Wilhelm A, Jahn A, Sedding D, Amarie OV, Eul B, Seeger W, Fink L, Gunther A, Eickelberg O, Rose F (2007) The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am J Respir Cell Mol Biol 37(6):640\u2013650","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"146","key":"1027_CR39","doi-asserted-by":"publisher","first-page":"170057","DOI":"10.1183\/16000617.0057-2017","volume":"26","author":"LH Lancaster","year":"2017","unstructured":"Lancaster LH, de Andrade JA, Zibrak JD, Padilla ML, Albera C, Nathan SD, Wijsenbeek MS, Stauffer JL, Kirchgaessler KU, Costabel U (2017) Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis. Eur Respir Rev 26(146):170057","journal-title":"Eur Respir Rev"},{"issue":"8","key":"1027_CR40","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.3390\/cells9081762","volume":"9","author":"G Latella","year":"2020","unstructured":"Latella G, Viscido A (2020) Could pirfenidone also be effective in treating intestinal fibrosis? Cells 9(8):1762","journal-title":"Cells"},{"issue":"3","key":"1027_CR41","doi-asserted-by":"publisher","first-page":"966","DOI":"10.21037\/jtd.2019.12.48","volume":"12","author":"JH Lee","year":"2020","unstructured":"Lee JH, Lim CM, Koh Y, Hong SB, Song JW, Huh JW (2020) High-flow nasal cannula oxygen therapy in idiopathic pulmonary fibrosis patients with respiratory failure. J Thorac Dis 12(3):966","journal-title":"J Thorac Dis"},{"issue":"1","key":"1027_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-020-01590-y","volume":"22","author":"DJ Leeming","year":"2021","unstructured":"Leeming DJ, Genovese F, Sand JM, Rasmussen DG, Christiansen C, Jenkins G, Maher TM, Vestbo J, Karsdal MA (2021) Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis. Respir Res 22(1):1\u20137","journal-title":"Respir Res"},{"issue":"6","key":"1027_CR43","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.201701-0091OC","volume":"196","author":"B Ley","year":"2017","unstructured":"Ley B, Swigris J, Day BM, Stauffer JL, Raimundo K, Chou W, Collard HR (2017) Pirfenidone reduces respiratory-related hospitalizations in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 196(6):756\u2013761","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1027_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"SW Li","year":"2016","unstructured":"Li SW, Wang CY, Jou YJ, Yang TC, Huang SH, Wan L, Lin YJ, Lin CW (2016) SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-\u03b21 via ROS\/p38 MAPK\/STAT3 pathway. Sci Rep 6(1):1\u20133","journal-title":"Sci Rep"},{"issue":"1","key":"1027_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"C Li","year":"2017","unstructured":"Li C, Han R, Kang L, Wang J, Gao Y, Li Y, He J, Tian J (2017) Pirfenidone controls the feedback loop of the AT1R\/p38 MAPK\/renin-angiotensin system axis by regulating liver X receptor-\u03b1 in myocardial infarction-induced cardiac fibrosis. Sci Rep 7(1):1\u20131","journal-title":"Sci Rep"},{"issue":"6","key":"1027_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007572","volume":"7","author":"Y Li","year":"2018","unstructured":"Li Y, Li L, Qian Z, Lin B, Chen J, Luo Y, Qu J, Raj JU, Gou D (2018) Phosphatidylinositol 3-Kinase\u2013DNA Methyltransferase 1\u2013miR-1281\u2013histone deacetylase 4 regulatory axis mediates platelet-derived growth factor-induced proliferation and migration of pulmonary artery smooth muscle cells. J Am Heart Assoc 7(6):e007572","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1027_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-017-0405-7","volume":"17","author":"Y Liu","year":"2017","unstructured":"Liu Y, Lu F, Kang L, Wang Z, Wang Y (2017) Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2\/Bach1 equilibrium. BMC Pulm Med 17(1):1\u20131","journal-title":"BMC Pulm Med"},{"issue":"2","key":"1027_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbrc.2019.01.104","volume":"510","author":"B Liu","year":"2019","unstructured":"Liu B, Rong Y, Sun D, Li W, Chen H, Cao B, Wang T (2019) Costunolide inhibits pulmonary fibrosis via regulating NF-kB and TGF-\u03b21\/Smad2\/Nrf2-NOX4 signaling pathways. Biochem Biophys Res Commun 510(2):329\u2013333","journal-title":"Biochem Biophys Res Commun"},{"key":"1027_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114431","volume":"185","author":"C Lugnier","year":"2021","unstructured":"Lugnier C, Al-Kuraishy HM, Rousseau E (2021) PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking. Biochem Pharmacol 185:114431","journal-title":"Biochem Pharmacol"},{"key":"1027_CR50","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, Meng Z, Chen R, Guan KL (2019) The Hippo pathway: biology and pathophysiology. Annu Rev Biochem 88:577\u2013604","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"1027_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","volume":"8","author":"TM Maher","year":"2020","unstructured":"Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Samara K, Gilberg F, Cottin V (2020) Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med 8(2):147\u2013157","journal-title":"Lancet Respir Med"},{"issue":"4","key":"1027_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249644","volume":"16","author":"R Mahmud","year":"2021","unstructured":"Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SJ, Islam MS, Islam MM (2021) Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS\u00a0One 16(4):e0249644","journal-title":"PLoS\u00a0One"},{"issue":"3","key":"1027_CR53","first-page":"e13923","volume":"13","author":"B Malik","year":"2021","unstructured":"Malik B, Abdelazeem B, Ghatol A (2021) Pulmonary fibrosis after COVID-19 Pneumonia. Cureus. 13(3):e13923","journal-title":"Cureus."},{"issue":"6","key":"1027_CR54","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1164\/ajrccm.161.6.9907004","volume":"161","author":"RP Marshall","year":"2000","unstructured":"Marshall RP, McANULTY RJ, Laurent GJ (2000) Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 161(6):1999\u20132004","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1027_CR55","doi-asserted-by":"publisher","first-page":"L257","DOI":"10.1152\/ajplung.00238.2020","volume":"320","author":"LT McDonald","year":"2020","unstructured":"McDonald LT (2020) Healing after Covid-19: are survivors at risk for development of pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol 320(2):L257\u2013L265","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"1027_CR56","doi-asserted-by":"publisher","first-page":"2001217","DOI":"10.1183\/13993003.01217-2020","volume":"55","author":"X Mo","year":"2020","unstructured":"Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, Lei C, Chen R, Zhong N, Li S (2020) Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 55(6):2001217","journal-title":"Eur Respir J"},{"key":"1027_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-022-00993-1","volume":"30","author":"G Mostafa-Hedeab","year":"2022","unstructured":"Mostafa-Hedeab G, Al-Kuraishy HM, Al-Gareeb AI, Jeandet P, Saad HM, Batiha GES (2022) A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19. Inflammopharmacology 30:1\u201311","journal-title":"Inflammopharmacology"},{"issue":"23","key":"1027_CR58","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1158\/0008-5472.CAN-18-3927","volume":"79","author":"S Muralidhar","year":"2019","unstructured":"Muralidhar S, Filia A, Nsengimana J, Po\u017aniak J, O\u2019Shea SJ, Diaz JM, Harland M, Randerson-Moor JA, Reichrath J, Laye JP, van der Weyden L (2019) Vitamin D-VDR signaling inhibits Wnt\/\u03b2-catenin\u2013mediated melanoma progression and promotes antitumor immunity. Cancer Res 79(23):5986\u20135998","journal-title":"Cancer Res"},{"issue":"2","key":"1027_CR59","doi-asserted-by":"publisher","first-page":"F436","DOI":"10.1152\/ajprenal.00162.2011","volume":"301","author":"KA Nath","year":"2011","unstructured":"Nath KA, Croatt AJ, Warner GM, Grande JP (2011) Genetic deficiency of Smad3 protects against murine ischemic acute kidney injury. Am J Physiol Renal Physiol 301(2):F436\u2013F442","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"1027_CR60","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.3390\/ijms19113674","volume":"19","author":"S Noguchi","year":"2018","unstructured":"Noguchi S, Saito A, Nagase T (2018) YAP\/TAZ signaling as a molecular link between fibrosis and cancer. Int J Mol Sci 19(11):3674","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1027_CR61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/path.3992","volume":"228","author":"JJ Osterholzer","year":"2012","unstructured":"Osterholzer JJ, Christensen PJ, Lama V, Horowitz JC, Hattori N, Subbotina N, Cunningham A, Lin Y, Murdock BJ, Morey RE, Olszewski MA (2012) PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury. J Pathol 228(2):170\u2013180","journal-title":"J Pathol"},{"issue":"69","key":"1027_CR62","first-page":"11","volume":"16","author":"SC Quay","year":"2019","unstructured":"Quay SC, Chen SC, Rea J, Remmel HL (2019) AT-H201 constituents collectively are the most potent inhibitors of SARS-CoV-2 infectivity in VERO cells identified and mechanistically act as a chemical vaccine: Human safety data support rapid clinical development as inhaled therapy for COVID-19. Virol J 16(69):11\u201319.","journal-title":"Virol J"},{"issue":"3","key":"1027_CR63","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00580-020-03104-0","volume":"29","author":"R Rasooli","year":"2020","unstructured":"Rasooli R, Kamali Y, Mandegary A (2020) Effects of pirfenidone, vitamin E, and pirfenidone\u2013vitamin E combination in paraquat-induced pulmonary fibrosis. Comp Clin Path 29(3):667\u2013673","journal-title":"Comp Clin Path"},{"key":"1027_CR64","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fphys.2018.00180","volume":"9","author":"A Rathinasabapathy","year":"2018","unstructured":"Rathinasabapathy A, Horowitz A, Horton K, Kumar A, Gladson S, Unger T, Martinez D, Bedse G, West J, Raizada MK, Steckelings UM (2018) The selective angiotensin II type 2 receptor agonist, compound 21, attenuates the progression of lung fibrosis and pulmonary hypertension in an experimental model of bleomycin-induced lung injury. Front Physiol 9:180","journal-title":"Front Physiol"},{"issue":"3","key":"1027_CR65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201707","volume":"218","author":"TS Rodrigues","year":"2020","unstructured":"Rodrigues TS, de S\u00e1 KS, Ishimoto AY, Becerra A, Oliveira S, Almeida L, Gon\u00e7alves AV, Perucello DB, Andrade WA, Castro R, Veras FP (2020) Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med 218(3):e20201707","journal-title":"J Exp Med"},{"key":"1027_CR66","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.40","volume":"44","author":"SG Rosa","year":"2020","unstructured":"Rosa SG, Santos WC (2020) Clinical trials on drug repositioning for COVID-19 treatment. Rev Panam Salud Publica 44:e40","journal-title":"Rev Panam Salud Publica"},{"issue":"11","key":"1027_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015521","volume":"5","author":"S Saraswati","year":"2010","unstructured":"Saraswati S, Alfaro MP, Thorne CA, Atkinson J, Lee E, Young PP (2010) Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PLoS\u00a0One 5(11):e15521","journal-title":"PLoS\u00a0One"},{"issue":"6","key":"1027_CR68","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/jclinpath-2020-206879","volume":"74","author":"HF Schwensen","year":"2020","unstructured":"Schwensen HF, Borreschmidt LK, Storgaard M, Redsted S, Christensen S, Madsen LB (2020) Fatal pulmonary fibrosis: a post-COVID-19 autopsy case. J Clin Pathol 74(6):400\u2013402","journal-title":"J Clin Pathol"},{"key":"1027_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110005","volume":"144","author":"S Seifirad","year":"2020","unstructured":"Seifirad S (2020) Pirfenidone: a novel hypothetical treatment for COVID-19. Med Hypotheses 144:110005","journal-title":"Med Hypotheses"},{"issue":"2","key":"1027_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1165\/rcmb.2016-0147OC","volume":"56","author":"JA Sennello","year":"2017","unstructured":"Sennello JA, Misharin AV, Flozak AS, Berdnikovs S, Cheresh P, Varga J, Kamp DW, Budinger GS, Gottardi CJ, Lam AP (2017) Lrp5\/\u03b2-catenin signaling controls lung macrophage differentiation and inhibits resolution of fibrosis. Am J Respir Cell Mol Biol 56(2):191\u2013201","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"1027_CR71","first-page":"e12482","volume":"13","author":"PV Shah","year":"2021","unstructured":"Shah PV, Balani P, Lopez AR, Nobleza CM, Siddiqui M, Khan S (2021) A review of pirfenidone as an anti-fibrotic in idiopathic pulmonary fibrosis and its probable role in other diseases. Cureus 13(1):e12482","journal-title":"Cureus"},{"key":"1027_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118454","volume":"260","author":"MH Sharawy","year":"2020","unstructured":"Sharawy MH, Serrya MS (2020) Pirfenidone attenuates gentamicin-induced acute kidney injury by inhibiting inflammasome-dependent NLRP3 pathway in rats. Life Sci 260:118454","journal-title":"Life Sci"},{"issue":"4","key":"1027_CR73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/08830185.2020.1756284","volume":"39","author":"A Shneider","year":"2020","unstructured":"Shneider A, Kudriavtsev A, Vakhrusheva A (2020) Can melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol 39(4):153\u2013162","journal-title":"Int Rev Immunol"},{"issue":"5","key":"1027_CR74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s11523-017-0507-4","volume":"12","author":"R Tabatabai","year":"2017","unstructured":"Tabatabai R, Linhares Y, Bolos D, Mita M, Mita A (2017) Targeting the Wnt pathway in cancer: a review of novel therapeutics. Target Oncol 12(5):623\u2013641","journal-title":"Target Oncol"},{"key":"1027_CR75","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/PPA.S37233","volume":"8","author":"Y Takeda","year":"2014","unstructured":"Takeda Y, Tsujino K, Kijima T, Kumanogoh A (2014) Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis. Patient Prefer Adherence 8:361","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"1027_CR76","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1183\/09031936.00005209","volume":"35","author":"H Taniguchi","year":"2010","unstructured":"Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Takeuchi M (2010) Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35(4):821\u2013829","journal-title":"Eur Respir J"},{"issue":"2","key":"1027_CR77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/cmrp.cmrp_110_21","volume":"12","author":"M Tanvir","year":"2022","unstructured":"Tanvir M, Wagay I, Nisar S, Ahmed RN, Maqbool M, Kareem O, Muzaffer U (2022) 2022 Early intervention with anti-fibrotic pirfenidone is effective than corticosteroids in preventing pulmonary fibrosis in severe COVID pneumonia patients. Curr Med Res Pract 12(2):53","journal-title":"Curr Med Res Pract"},{"issue":"3","key":"1027_CR78","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/1043-4666(90)90018-O","volume":"2","author":"M Turner","year":"1990","unstructured":"Turner M, Chantry D, Feldmann M (1990) Transforming growth factor \u03b2 induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine 2(3):211\u2013216","journal-title":"Cytokine"},{"issue":"7","key":"1027_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/lungindia.lungindia_818_20","volume":"38","author":"ZF Udwadia","year":"2021","unstructured":"Udwadia ZF, Koul PA, Richeldi L (2021a) a) Post-COVID lung fibrosis: the tsunami that will follow the earthquake. Lung India 38(7):41","journal-title":"Lung India"},{"issue":"7","key":"1027_CR80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/lungindia.lungindia_533_20","volume":"38","author":"ZF Udwadia","year":"2021","unstructured":"Udwadia ZF, Pokhariyal PK, Tripathi AK, Kohli A (2021b) Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids. Lung India 38(7):61","journal-title":"Lung India"},{"key":"1027_CR81","doi-asserted-by":"publisher","DOI":"10.33590\/emj\/20-00159","author":"TJ Walsh","year":"2020","unstructured":"Walsh TJ (2020) Primer on the pathogenesis of Severe COVID-19: part two. EMJ. https:\/\/doi.org\/10.33590\/emj\/20-00159","journal-title":"EMJ"},{"key":"1027_CR82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.virusres.2017.04.008","volume":"235","author":"CY Wang","year":"2017","unstructured":"Wang CY, Lu CY, Li SW, Lai CC, Hua CH, Huang SH, Lin YJ, Hour MJ, Lin CW (2017) SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-\u03b21 signaling. Virus Res 235:58\u201366","journal-title":"Virus Res"},{"issue":"29","key":"1027_CR83","doi-asserted-by":"publisher","first-page":"e16531","DOI":"10.1097\/MD.0000000000016531","volume":"98","author":"Y Xie","year":"2019","unstructured":"Xie Y, Wang Y, Liu K, Li X (2019) Correlation analysis between mechanical power, transforming growth factor-\u03b21, and connective tissue growth factor levels in acute respiratory distress syndrome patients and their clinical significance in pulmonary structural remodeling. Medicine 98(29):e16531","journal-title":"Medicine"},{"issue":"6","key":"1027_CR84","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.7150\/ijbs.58825","volume":"17","author":"M Xue","year":"2021","unstructured":"Xue M, Zhang T, Chen H, Zeng Y, Lin R, Zhen Y, Li N, Huang Z, Hu H, Zhou L, Wang H (2021) Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients. Int J Biol Sci 17(6):1565\u20131573","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1027_CR85","first-page":"1119","volume":"12","author":"EC Yo","year":"2021","unstructured":"Yo EC, Kadharusman MM, Karman AP, Louisa M, Arozal W (2021) Potential pharmacological options and new avenues using inhaled curcumin nanoformulations for treatment of post-COVID-19 fibrosis. Syst Rev Pharm 12(1):1119\u20131128","journal-title":"Syst Rev Pharm"},{"issue":"4","key":"1027_CR86","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.210773.112","volume":"27","author":"FX Yu","year":"2013","unstructured":"Yu FX, Guan KL (2013) The Hippo pathway: regulators and regulations. Genes Dev 27(4):355\u2013371","journal-title":"Genes Dev"},{"issue":"2","key":"1027_CR87","doi-asserted-by":"publisher","first-page":"2001526","DOI":"10.1183\/13993003.01526-2020","volume":"56","author":"HQ Yu","year":"2020","unstructured":"Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, Zheng PY (2020) Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J 56(2):2001526","journal-title":"Eur Respir J"},{"issue":"1","key":"1027_CR88","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","volume":"21","author":"H Zhang","year":"2017","unstructured":"Zhang H, Baker A (2017) Recombinant human ACE2: acing out angiotensin II in ARDS therapy. Crit Care 21(1):305. https:\/\/doi.org\/10.1186\/s13054-017-1882-z","journal-title":"Crit Care"},{"issue":"3","key":"1027_CR89","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/jmv.26634","volume":"93","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wu Z, Li JW, Tan K, Yang W, Zhao H, Wang GQ (2020a) Discharge may not be the end of treatment: pay attention to pulmonary fibrosis caused by severe COVID-19. J Med Virol 93(3):1378\u20131386","journal-title":"J Med Virol"},{"issue":"1","key":"1027_CR90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-019-0078-3","volume":"8","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, Chen L, Jiang M, Pan F, Zheng Y, Gao Z (2020b) Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res 8(1):1\u20138","journal-title":"Bone Res"},{"issue":"03","key":"1027_CR91","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/CM9.0000000000001614","volume":"135","author":"F Zhang","year":"2022","unstructured":"Zhang F, Wei Y, He L, Zhang H, Hu Q, Yue H, He J, Dai H (2022) A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019. Chin Med J 135(03):368\u2013370","journal-title":"Chin Med J"},{"issue":"4","key":"1027_CR92","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/ijms19041118","volume":"19","author":"X Zhao","year":"2018","unstructured":"Zhao X, Sun J, Su W, Shan H, Zhang B, Wang Y, Shabanova A, Shan H, Liang H (2018) Melatonin protects against lung fibrosis by regulating the Hippo\/YAP pathway. Int J Mol Sci 19(4):1118","journal-title":"Int J Mol Sci"},{"key":"1027_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100463","volume":"25","author":"YM Zhao","year":"2020","unstructured":"Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, Jia JL, Li LM, Mao HL, Zhou XM, Luo H (2020) Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 25:100463","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1027_CR94","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11010-020-03866-9","volume":"475","author":"T Zhu","year":"2020","unstructured":"Zhu T, Ma Z, Wang H, Jia X, Wu Y, Fu L, Li Z, Zhang C, Yu G (2020) YAP\/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways. Mol Cell Biochem 475(1):137\u2013149","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"1027_CR95","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1165\/rcmb.2018-0142OC","volume":"60","author":"K Zmajkovicova","year":"2019","unstructured":"Zmajkovicova K, Menyhart K, Bauer Y, Studer R, Renault B, Schnoebelen M, Bolinger M, Nayler O, Gatfield J (2019) The antifibrotic activity of prostacyclin receptor agonism is mediated through inhibition of YAP\/TAZ. Am J Respir Cell Mol Biol 60(5):578\u2013591","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1027_CR96","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.12659\/MSM.907891","volume":"23","author":"WJ Zou","year":"2017","unstructured":"Zou WJ, Huang Z, Jiang TP, Shen YP, Zhao AS, Zhou S, Zhang S (2017) Pirfenidone inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells by inhibiting the Wnt\/\u03b2-catenin signaling pathway. Med Sci Monit 23:6107","journal-title":"Med Sci Monit"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01027-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T22:57:52Z","timestamp":1669417072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01027-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01027-6","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}